LISA TURNER: Open Payments
NPI 1316725161 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 34 payments from 11 companies in 2025. Trend: 2023 $196 · 2024 $753 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $199 |
| Novo Nordisk Inc | 6 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $105 |
| Lilly USA, LLC | 3 | $65 |
| PFIZER INC. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
| Astellas Pharma US Inc | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
Products named: AIRSUPRA, Kerendia, Ozempic, GARDASIL 9, MOUNJARO, ZENPEP, Cologuard Collection Kit, Veozah.
Industry payments across AZ — which companies pay providers there.
